Industry

The Accelerating Cures Institute can guide potential targets, therapeutic agents, or clinical trials to success. NACI collaborates with the NIH-funded Nephrotic Syndrome Study Network (NEPTUNE) to create a comprehensive drug development and clinical trials pipeline.

NACI’s Strategic Advantages

. .
Efficiency Partnerships Resources
  • Single Network Reliance IRB
  • Master contract with protocol riders to support efficient research implementation
  • Private and academic practices with research experience
  • Adult and pediatric patients and practices
  • Pharmaceutical industry members
  • International key opinion leaders across the field
  • Patient Advisory Board
  • Clinical Trial Consulting Team
  • Standard analysis files for Network registry
  • CFR Part 11 Compliant database
  • Patient-oriented educational materials and resources

Conduct clinical trials with expertise to ensure completion and success

Launched in 2015, NACI leverages established partnerships with over 15 years of high value experience.

  • Multiple experts in trial design and conduct, including nephrology trials in adults and children
  • NACI Network of experienced, trial ready sites
  • Active patient and provider engagement and education
  • Reputable Data Coordinating Center: SABER (37 multi and single center studies, including 17 RCTs)